Category: Approval/Launch Region: Asia · India Company: Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals launches 750 mg injectable Ferric Carboxymaltose

Emcure Pharmaceuticals launches 750 mg injectable Ferric Carboxymaltose
Becomes first Indian player to launch 750mg injectable variant of FCM to fight iron deficiency anaemia In a bid to provide effective and convenient option for patients with iron deficiency and iron deficiency anaemia (IDA), Emcure Pharmaceuticals Limited (EPL) has launched Orofer FCM 750, a new extension of its parenteral iron brand containing Ferric carboxymaltose (FCM). This makes Emcure India

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!